Kalaris Therapeutics (KLRS) Enterprise Value (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Enterprise Value data on record, last reported at -$378.5 million in Q3 2020.
- For Q3 2020, Enterprise Value changed N/A year-over-year to -$378.5 million; the TTM value through Sep 2020 reached -$378.5 million, changed N/A, while the annual FY2019 figure was -$126.1 million, N/A changed from the prior year.
- Enterprise Value reached -$378.5 million in Q3 2020 per KLRS's latest filing, down from -$104.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$104.5 million in Q2 2020 and bottomed at -$378.5 million in Q3 2020.